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Abstract
The unambiguous demarcation of tumor margins is critical at the final stages in the surgical treatment of brain tumors
because patient outcomes have been shown to correlate with the extent of resection. Real-time high-resolution im-
aging with the aid of a tumor-targeting fluorescent contrast agent has the potential to enable intraoperative differ-
entiation of tumor versus normal tissues with accuracy approaching the current gold standard of histopathology. In
this study, a monoclonal antibody targeting the vascular endothelial growth factor receptor 1 (VEGFR-1) was con-
jugated to fluorophores and evaluated as a tumor contrast agent in a transgenic mouse model of medulloblastoma.
The probe was administered topically, and its efficacy as an imaging agent was evaluated in vitro using flow cytom-
etry, as well as ex vivo on fixed and fresh tissues through immunohistochemistry and dual-axis confocal microscopy,
respectively. Results show a preferential binding to tumor versus normal tissue, suggesting that a topically applied
VEGFR-1 probe can potentially be used with real-time intraoperative optical sectioning microscopy to guide brain
tumor resections.
Translational Oncology (2012) 5, 408–414
Introduction
Medulloblastoma is the most common malignant pediatric brain tu-
mor. Despite the availability and advancement of medical technologies,
patient prognoses remain poor [1,2]. Bulk tumor resection remains the
first line of treatment, where it has been shown that the completeness of
tumor resection correlates strongly with the survival of patients [1–3].
The goal of neurosurgeons is to maximize the removal of tumor while
minimizing the removal of normal tissues. The current gold standard
for assessing malignancy is histopathology of biopsied tissue samples.
However, this is rarely performed at the tumor margins during resec-
tion because of the time required for frozen sections to be prepared and
interpreted by a pathologist. Furthermore, histopathology is expensive
and requires the removal of brain tissue regardless of the state of the
tissue. Therefore, there is a need for a noninvasive method to rapidly
and accurately visualize residual malignancy to assist surgeons during
the tumor resection process.
In previous work, we developed a handheld dual-axis confocal
(DAC) microscope for intraoperative optical biopsy at the tumor mar-
gins [4]. An optical sectioning microscope with cellular resolution has
the potential to provide highly accurate confirmation of tissue status
with the possibility of optimizing and complementing low-resolution
wide-field imaging approaches such as fluorescence image–guided
surgery [5–7]. Reports from early preclinical and clinical studies sug-
gest that intraoperative confocal microscopy can play a valuable role
in guiding tumor resection, especially in certain tumor types that do
not image well with wide-field techniques [8–11].
In this study, we are developing a contrast agent to be used in
conjunction with point-of-care confocal microscopes and other forms
of fluorescence imaging. The vascular endothelial growth factor re-
ceptor 1 (VEGFR-1) and other tyrosine kinase receptors have been
shown to be overexpressed on the surface of human medulloblastoma
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cell lines as well as on tumor cells in excised human medulloblastoma
tissues [12], suggesting that VEGFR-1 plays a role in the development
of medulloblastoma and could be a molecular target for therapeutic
and imaging agents. To explore the feasibility of a VEGFR-1 imaging
agent, we first demonstrated that VEGFR-1 is overexpressed in a trans-
genic mouse model of medulloblastoma and developed a fluorescent
VEGFR-1 probe that could be topically applied on fresh tissues to
provide molecular image contrast in this predictive animal model.
Materials and Methods
Transgenic Mouse Model
The ptc+/−p53−/−Math1-GFP medulloblastoma mouse model was
developed previously [13,14]. These mice, which are heterozygous
knockouts for ptc and homozygous knockouts for p53, develop medullo-
blastoma with 95% penetrance at 3 to 5 weeks of age. The tumor
cells in these mice express green fluorescent protein (GFP) as driven
by a Math1 promoter, a developmental gene that is overexpressed
in medulloblastoma.
Multiwavelength DAC Microscope
A custom multiwavelength DAC microscope was developed previ-
ously [15,16]. The DAC architecture allows for relatively deep optical
sectioning within tissues, as demonstrated through diffraction theory
modeling [17], Monte Carlo scattering simulations, tissue-phantom
measurements [15], and imaging studies [15,17]. All imaging experi-
ments of fresh thick tissues in this study were performed using the
DAC microscope, which acquires serial vertical image sections across
a three-dimensional volume of tissue with a maximum field of view
of 600 × 800 μm and a depth of 500 μm (maximum depth varies
with tissue type). The spatial resolution of the microscope is approxi-
mately 2 μm in the lateral directions and 3 μm in the vertical direction
(depending on wavelength and imaging depth). Image sections are
acquired at 2 frames/second with a 1-μm step size between serial ver-
tical sections. Laser sources at 488, 660, and 785 nm were used for
imaging fluorescence from GFP, Alexa Fluor 647 (AF647), and Licor
IRDye 800CW, respectively. In this study, the microscope was used
for two-channel imaging at 488 and 660 nm or at 660 and 785 nm.
Probe Conjugation
Monoclonal VEGFR-1 antibodies (Abcam, Cambridge, MA;
ab51872) were conjugated with AF647 dye and purified using a label-
ing kit (Invitrogen, Grand Island, NY; A-20186). The labeling efficiency
and yield were verified by spectrophotometry. Typical post-purification
antibody yields were more than 80% with a labeling ratio of approxi-
mately five dye molecules per antibody, within the manufacturer’s sug-
gested range of three to seven dyemolecules per antibody. Isotype control
antibodies (Rat IgG2a) were purchased pre-conjugated to AF647
(eBioscience, San Diego, CA; 51-4321-82) with an average labeling
ratio of three to seven dye molecules per antibody.
Primary Cell Culture
Primary medulloblastoma cells were isolated from the cerebellum of
transgenic mice based on a protocol described previously [18]. In brief,
the cerebellar tissue was coarsely minced with a sterile scalpel and
digested using papain (2 mg/ml; Sigma-Aldrich, St Louis, MO) at
37°C for an hour. The digested tissue was triturated and passed through
a 40-μm cell strainer to yield the final single-cell suspension. The cells
were either immediately used for flow cytometric analysis or maintained
for future use as neurosphere suspensions in Neurobasal/B27-without-
Vitamin-A medium with non-essential amino acids, 1 mM L-gluta-
mine, 1% penicillin/streptomycin, and 1% sodium pyruvate and sup-
plemented with epidermal growth factor and β-fibroblast growth factor.
Gross confirmation of the success of primary tumor cell isolation was
done visually using a blue light source and GFP viewing filter (Nightsea,
Inc, Bedford, MA).
Flow Cytometry
Isolated primary cerebellar cell samples were stained using AF647-
conjugated VEGFR-1 monoclonal antibody (mAb) or an AF647-
conjugated isotype control mAb. Samples were incubated for 15 minutes
at room temperature and rinsed once using phosphate-buffered saline
(PBS)/FBS buffer before flow cytometric analysis was performed with a
FACSCalibur flow cytometer (BD Biosciences, San Jose, CA). Analyses
were performed using Flowjo software to confirm the co-localization of
GFP and AF647 (VEGFR-1) on the primary cells.
Immunohistochemistry
Cerebellar tissues obtained from the transgenic medulloblastoma
mice were fixed in ice-cold 4% paraformaldehyde for 1 hour and
cryoprotected through dehydration using a 30% sucrose solution in
PBS overnight. The preserved tissues were frozen in optical cutting
temperature compound, sectioned with a cryotome at a thickness of
20 μm (at −18°C), and mounted onto slides. Each slide contained three
consecutive brain sections, which were stained with AF647-conjugated
VEGFR-1 antibodies, matching AF647-conjugated isotype antibody,
and PBS, respectively. Staining durations ranged from 5 to 15 minutes
and were limited to these short durations to mimic the conditions that
will eventually be required for in vivo surgical use. Stained slides were
rinsed for 5 minutes in PBS and then sealed with an aqueous mounting
media and a coverslip. The slides were imaged with a commercial
confocal microscope (Leica TCS SP5 II) to visualize the co-localization
of GFP-expressing tumors and the AF647 dye (VEGFR-1 mAb) at the
tumor margins. Image panels were analyzed using ImageJ [19]. A total
of n = 17 different tumor margin locations from different animals were
imaged. For each image of a tumor margin, five regions of interest
(ROIs) were selected from within the tumor region as well as within
the normal region (10 ROIs in total). Images obtained from the
GFP channel were used to identify tumor versus normal regions. An
average signal intensity was determined for each tumor and normal
ROI, and these signals were again averaged across the five tumor ROIs
and the five normal ROIs to determine a tumor-to-normal intensity
ratio for each image.
DAC Microscopy of Fresh Thick Tissues
Freshly excised thick tumor margins, identified macroscopically
using a blue light source and GFP viewing filter, were immediately
stained with AF647-conjugated VEGFR-1 mAb or AF647-conjugated
isotype control. Probe application on ex vivo tissue samples was per-
formed topically by soaking samples in a 0.1 mg/ml probe solution
prepared with 5% DMSO in PBS for 10 minutes, followed by rinse
removal of unbound probe by soaking the stained tissue three times
for 1 minute each in PBS. Numerous researchers have used up to
10% and 20% DMSO to enhance the delivery of contrast agents
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[20–22] for shallow subsurface imaging. Likewise, in this study, the
addition of 5% DMSO was used to enhance the permeation of our
antibody probes during topical delivery. Samples were imaged with a
custom multiwavelength DAC microscope, as described previously.
Serial vertical image sections were obtained, and image stacks were
volume-rendered using AMIRA software. Images of horizontal sections,
from depths ranging from 25 to 75 μm, were exported and analyzed
using ImageJ as was performed for images from physically sectioned
slides. Average tumor-to-normal pixel intensity ratios were calculated
from n = 20 samples of thick brain tissues from different animals.
Quantitative Ratiometric Imaging
To confirm and quantify the binding specificity of the VEGFR-1
probe during thick tissue microscopy, we used a previously developed
ratiometric imaging strategy [16]. This method involves the simul-
taneous imaging of a targeted (VEGFR-1 mAb) and an untargeted
(isotype control) probe. Freshly excised tumor-margin specimens were
stained with an equimolar mixture of Licor 800CW-conjugated
VEGFR-1 mAb (785-nm excitation) and AF647-conjugated isotype
mAb (660-nm excitation), incubated at room temperature for 10 min-
utes, and rinsed with PBS (three times). Before the imaging of tissue
specimens, system calibration was done by imaging an equimolar mix-
ture of the probe and isotype mAb solution at the exact laser and
detector gain settings used for subsequent tissue imaging. The ratio
of the average intensity from each channel was used as a calibration
factor for ratiometric quantification of specific versus nonspecific bind-
ing of the imaging probes in tissue, as detailed previously [16]. Images
were processed and calibrated in MATLAB (MathWorks, Natick,
MA) and ImageJ.
Statistical Analysis
Results summarized in Table 1 are presented as mean ± 1 standard
deviation. The normality of all data series was established using the
Shapiro-Wilk test. Median ratios are also presented in the table to
indicate that outliers, if present, do not affect the validity of our
assessments. Results were analyzed using an independent sample t test
as well as Wilcoxon test to determine statistical difference between the
tumor-to-normal ratios of isotype and probe-stained tissues. In both
cases, the significance level was set as α = 0.01. All statistical analyses
were performed using the Analyse-it add-in to Microsoft Excel.
Results
Flow Cytometry of Primary Cultured Cells
Preliminary flow cytometry of primary cultured cerebellar cells
revealed that a subpopulation of GFP-expressing medulloblastoma
cells (∼5%) exhibited a significant elevated expression (10-fold to
100-fold) of VEGFR-1. These results provided motivation to pursue
immunohistochemistry (IHC) analysis and, later, DAC microscopy
of fresh thick tissues.
Immunohistochemistry
Fixed frozen sections of mouse medulloblastoma tissue show clear
preferential binding of VEGFR-1 mAb to tumor in comparison to
normal tissue, while the isotype control shows relatively uniform non-
specific binding to both tumor and normal regions (Figure 1). Average
tumor-to-normal intensity ratios are calculated for n = 17 samples by
taking the ratio of the average intensity from five tumor and five nor-
mal ROIs within each tissue section. The average tumor-to-normal
intensity ratio is 1.84 ± 0.26 for VEGFR-1 probe–stained slides and
1.36 ± 0.25 for the isotype-stained counterparts. The box-and-whisker
plot in Figure 1G shows the results from n = 17 different tumor mar-
gin locations from different animals. Each box plot presents the full-
range distribution of the data set indicating the 25th, 50th, and 75th
percentiles along with the maximum and minimum values. The statis-
tical difference between the two groups was found to be significant at
P < .01. The tumor-to-normal intensity ratios for the representative
images shown in Figure 1, B and E , are 1.72 and 1.08, respectively.
DAC Microscopy of Fresh Thick Tissues
Freshly excised mouse medulloblastoma margins stained with AF647-
conjugated VEGFR-1mAb show clear co-localization with GFP-positive
tumor tissues, while the isotype control does not (Figure 2, A and B).
Average tumor-to-normal intensity ratios are calculated for n = 20 fresh
thick tissue samples by taking the ratio of the average intensity from five
tumor and five normal ROIs within each tissue at a single optical sec-
tion depth. The average tumor-to-normal intensity ratio is 3.46 ± 1.18
for VEGFR-1–stained tissues and 1.81 ± 0.65 for isotype-stained thick
tissue specimens. The box-and-whisker plot in Figure 2C shows the
results from n = 20 different tumor margin locations from different
animals. Each box plot presents the full range distribution of the data
set indicating the 25th, 50th, and 75th percentiles along with the maxi-
mum and minimum values. The statistical difference between the two
groups was found to be significant at P < .01. The tumor-to-normal
intensity ratios for the representative data shown in Figure 2, A and B,
are 3.78 and 1.76, respectively.
Table 1 summarizes the results from IHC analysis of fixed frozen
sections as well as DAC microscopy (optical sectioning) of fresh
thick tissues.
Quantitative Ratiometric Imaging
The ratiometric imaging method allows for the quantification of
molecularly specific versus nonspecific probe accumulation in a highly
controlled fashion. The motivation for this technique, in the context
of molecular microscopy with exogenous probes, will be discussed in
the following section. In our ratiometric imaging strategy, a specific
and a nonspecific probe are simultaneously applied onto tissue samples
and simultaneously imaged with complete spatial and temporal co-
registration [16]. The calibrated ratiometric image shown in Figure 3C
provides enhanced contrast between tumor (bottom left of image) and
normal tissue (upper right of image) and also provides a quantitative
display of the concentration of VEGFR-1–specific probe (C specific) versus
the concentration of nonspecific probe (Cnonspecific). Line-profile anal-
ysis is done along the lines shown in Figure 3, A to C , to further
Table 1. Summary of Imaging Analysis.
Groups n Staining Median T/N Ratio Average T/N Ratio
Fixed sections 17 VEGFR-1 1.77 1.84 ± 0.26
17 Isotype 1.32 1.36 ± 0.25
Fresh thick tissue 20 VEGFR-1 3.25 3.46 ± 1.18
20 Isotype 1.88 1.81 ± 0.65
The sample size n is defined as the number of frozen sections for IHC and the number of tumor-
margin specimens obtained from different animals for fresh tissue imaging.
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Figure 2. DAC microscope images of freshly excised thick tumor-margin specimens of medulloblastoma. (A) Volume rendering of GFP-
expressing medulloblastoma and VEGFR-1 probe (overlay on the left and individual image channels on the right). (B) Volume rendering of
GFP-expressing medulloblastoma and isotype control probe (overlay on the left and individual image channels on the right). (C) Tumor-to-
normal intensity ratio for tissues stained with the isotype control probe and the VEGFR-1 probe. Scale bar indicates 100 μm.
Figure 1. Physically sectioned tumor margins. Green channel: GFP-expressing tumor (A, D). Red channel: tissue stained with AF647-
conjugated VEGFR-1 mAb (B) and AF647-conjugated isotype control (E). Bright-field images of the medulloblastoma tissue sections
(C, F). Tumor-to-normal intensity ratio for tissue sections stained with the isotype control probe and the VEGFR-1 probe (G). Scale bar
indicates 100 μm.
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demonstrate the ratiometric calibrated imaging technique (Figure 3, D
and E ). The histogram in Figure 3F displays the normalized dis-
tribution of specific versus nonspecific probe concentrations (C specific/
Cnonspecific − 1) for ROIs within the tumor and normal regions of
the optical section shown in Figure 3C .
Discussion
Flow cytometry of primary cultured cells from our mouse medullo-
blastoma model was first used to screen for VEGFR-1 overexpression
by tumor cells. The results revealed high overexpression of VEGFR-1
(10-fold to 100-fold) in a subpopulation of cells and led to the pur-
suit of IHC and DAC microscopy experiments to explore the fea-
sibility of a VEGFR-1 probe for optical molecular imaging. The low
percentage of cells (∼5%) that stained positively for VEGFR-1 through
flow cytometry may have been due to the presence of VEGFR-1–
positive endothelial cells (GFP-negative) competing for the antibody
probe or removal of surface proteins by papain. However, because
the experimental conditions for this initial investigation differ signifi-
cantly from the intended imaging application, additional steps were not
taken to optimize the initial flow cytometry screening experiments.
IHC and DAC microscopy of fresh thick tissues were performed
to determine if our VEGFR-1 probe could provide adequate mo-
lecular image contrast to differentiate between tumor and normal
regions in intact tissues. It should be noted that, because our probes
are intended for real-time topical application during neurosurgery,
we limited our staining durations to a maximum of 10 to 15 minutes
to mimic the challenging time constraints of a clinical setting. Other
studies have previously demonstrated a similar rapid topical applica-
tion approach in the literature [22–24], with reported penetration
depths as high as 1 mm [25] with significant probe binding and/or
activation in as little as 1 to 5 minutes [23,24]. The fact that our
VEGFR-1 probe performs well under these short incubation time
constraints is a significant finding.
Results indicate that the VEGFR-1 probe is effective in differentiat-
ing between tumor and normal tissues at the margins. It is noted that
while the VEGFR-1 probe exhibits a significantly higher tumor-to-
normal intensity ratio than the isotype control probe (P < .01), the
tumor-to-normal ratios are elevated for both the specific and non-
specific probes. This may be due to an enhanced permeability and
retention effect that is seen in many tumors [26]. In our experience,
ambiguity in image contrast during in vivo molecular imaging can
Figure 3. Quantitative ratiometric imaging of a tumor-margin specimen. Raw fluorescence image of a tumor margin stained with (A) the
VEGFR-1 probe (785-nm fluorescence excitation) and (B) the isotype control probe (660-nm fluorescence excitation). (C) Calibrated ratio-
metric image that quantifies the specific versus nonspecific probe concentrations. The color map indicates the level of specific binding
(Cspecific) versus nonspecific probe accumulation (Cnonspecific). (D) Line-profile analysis of raw image intensities. (E) Line-profile analysis of
the calibrated ratiometric image. (F) Normalized histogram of specific versus nonspecific binding to tumor and normal tissues. Scale bar
indicates 50 μm.
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also be present due to nonspecific chemical binding, uneven probe
distribution, and/or poor washout of unbound probes. These prob-
lems are exacerbated during in vivo microscopy, because the small
fields of view provided by a microscope often prevent one from visual-
izing differential contrast between tumor and normal tissue regions
within a single image frame. By using a calibrated ratiometric imag-
ing method, we are able to distinguish between molecularly specific
and nonspecific probe binding and to quantify these levels at the cel-
lular level, thus providing an unambiguous determination of tissue
status within a single image. Recently, others have shown that this
technique may be used to quantify the binding potential of tumor re-
ceptors following the systemic delivery of a targeted and an untargeted
imaging agent [27].
The ability to resolve individual cells with intraoperative confocal
microscopy, while generally limited to a small field of view, may be
of great value in cases where tumor cells are loosely distributed, such
as at the margins of diffuse gliomas. In addition, certain probes,
though targeted, may only label a sparse subset of tumor cells. For
example, in recent years, fluorescence image–guided surgery with con-
trast provided by 5-aminolevulinic acid (5-ALA)–induced protopor-
phyrin IX fluorescence has been demonstrated to improve outcomes
for patients with high-grade gliomas (World Health Organization
Grades III and IV) [5,9,28]. Unfortunately, 5-ALA–induced proto-
porphyrin IX fluorescence is only generated in sparse proliferative cell
populations and is undetectable in low-grade gliomas (World Health
Organization Grades I and II) through wide-field techniques [29,30].
However, it has recently been reported that intraoperative cellular
resolution confocal microscopy can be used to visualize the sparse
fluorescent cells in low-grade glioma patients treated with 5-ALA
[9]. Therefore, intraoperative confocal microscopy has the potential
to serve as a valuable complement to wide-field techniques for the
image-guided resection of certain tumors.
Future plans are to investigate the ability of the VEGFR-1 fluores-
cent probe, used in conjunction with a surgical DAC microscope, to
enhance surgical resection in animal models. To achieve this goal, we
are developing a miniature multicolor DAC microscope for in vivo
ratiometric imaging of VEGFR-1 expression. Use of a transgenic mouse
model allows for the minimization of experimental variability while
optimizing these imaging technologies. However, our ultimate goal is
to translate these synergistic technologies into the clinic for guiding
brain tumor resection through the unambiguous real-time delineation
of tumor margins in human patients.
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